An open clinical trial was conducted to evaluate the efficacy of Hingwadichoorna on acute attack of Bronchial Asthma in children at SDM College of Ayurveda & Hospital, Kuthpady, Udupi. The trial was conducted on 34 patients, Hingwadichoorna was given in children of age group of 5years to 9yrs 11 months.The medicine was given 6 th hourly in a 4 divided dose per day for 7 days and with a follow up of 14 days. The response was assessed using various clinical, quantitative parameters and analyzed statistically using paired't' test and Wilcoxon Signed Rank Test. Statistically significant results obtained in subjective parameter and peak expiratory flow rate and hemoglobin, AEC. Study showed Hingwadichoorna is effective in combating the signs and symptoms of Tamakaswasa.
INTRODUCTION
Kaumarabhritya is one among Ashtanga Ayurveda which deals with children where it has been given importance like Agnidevata [1] . Balyavastha is stage where predominance of Kaphadosha, Aparipakwadhatu and Asampurnabala [2] which makes children more prone to diseases.
Respiratory system is continuously in contact with the external environment since birth. It is most vulnerable to infections and considered as prime victim of hyper sensitization in most of the circumstance. 14% of world's children experience Asthma symptoms [3] . The peak incidence of Bronchial Asthma is seen in 5-10yrs of age group [4] . It is responsible for significant social, economic and psychological impact on family. Acute Asthma leads to disturbed sleep, restricted day to day activities and school absenteeism [5] .
Pathological stipulation of Pranavahasrotas leads to manifestation of the disease named Swasaroga. Tamakaswasa is having its own etiology, pathology, management and is said to be sadhya [6] . The predominant morbidity of Vata and Kaphadosha, stemming out from Pittasthana affecting Rasadhatu, disturbing the functions of Pranavahasrotas, these pathological events collectively leads to occurrences of Tamakaswasa. In Ayurvedic classics mentioned about many ShamanaAuoshadi as it normalizes the aggravated Doshas [7] . Oral administration of Shamana drugs in the form of Choorna is of utmost importance to combating the signs and symptoms of Tamakaswasa in acute condition. Hence, Hingwadichoorna [8] is one of the formulation mentioned in the classics to control the Tamakaswasa and was taken as trial drug.
MATERIALS AND METHODS

Selection of cases:
Patients having signs and symptoms of Tamakaswasa were selected from the Kaumarabhritya OPD and IPD of SDM Ayurveda College and Hospital, Kuthpady, Udupi, after detailed history taking on the basis of specially prepared proforma.
Inclusion criteria
▪
Patients of either sex. ▪
Patients between the age group of 05 to 9yrs 11month. ▪
Patients with Ghurghurka(wheeze) and any two or more symptoms described in the context of Tamakaswasawereselected. 
Preparation of Hingwadichoorna
Hingwadichoorna prepared [9] and standardized [10] 
Statistical Evaluation
Statistical analysis was carried out using the software SPSS 20.0.The frequency calculations along with parametric and non-parametric test procedure had been performed. Parametric data within the group (Ex: comparison between BT, AT and FU) were tested with paired't'test, regard to significance. Wilcoxon Signed Rank test (non-parametric) was used for subjective criteria, with P value <0.05 was considered as statistically significant, P value 0.000 or 0.001 were considered as highly significant and P value > 0.05 was not significant.
Ethical clearance
This trial has been cleared by Institutional Ethical Comities, Reference Number. SDMCAU/ACA-49/ECA26/15-16 Chronic inflammatory disorder of lower airways characterized by recurrent episodes of variable, reversible airflow obstruction and airway hyper-responsiveness manifested as a recurrent wheeze and cough [11] . Intrauterine exposure,viral infection, diet, air pollution, genetics, endocrine factors are contributing for to cause the Asthma [12] .
OBSERVATION AND RESULTS
RESULTS
Discussion on observation related to disease
In the study, it was found 53.3% patients had episodic onset, which shows the nature of the disease. In 40% patients, time of occurrence was at night, because of pooling of mucous into the respiratory tract nature of disease which aggravate during night hours initial pathology attributed to the bronchospasm making the airflow obstruction.In Ayurveda, night is considered as Tamas predominant andKapha Kala, hence attack of Tamakaswasa is seen more during the night hours. 60% patients, wheeze was a preceding factor, wheeze is cardinal sign of Asthma [13] . 50% patients reported nebulization as relieving factor it suggests that nebulization with improvement (12-15%) is highly suggestive of reversible airway obstruction in asthma [14] . 85.3% patients had a history of RRTI, research study showed upper respiratory tract infection triggers Bronchial asthma [15] . 47.1% patients had familial allergy and genetic factor was responsible, the positive family history suggests genetic influence present in the parents which is responsible for producing abnormal amounts of lgE in response to exposure to environmental allergens [16] . 100% patients were of Kroorakostha, this might be due to the pratilomagati of Vata. 55.9% patients had dogs as a pet at home, research studies have shown increased incidence of bronchial asthma with patients having dogs as their pet [17] .
Discussion on results
The clinical trial revealed the efficacy of Hingwadichoorna in controlling the symptoms of respiratory system by virtue of its Kaphara and Vatanulomana properties. Pippali being Kaphara andKasa hara, it relieves bronchospasm andexpels the mucous out of the respiratory system.Piperine in Pippali acts as bronchodilator, by which it dilates the constricted bronchioles and there by reduces Swasakrichrata, Muhurshwasa, Ghurgurata. It has been proven that Pippali andBadara acts as anti-inflammatory [18] by which it can be assumed that it reduces the inflammation in respiratory system and reduces the pooling of the mucous, which is evident in significant results in Kasa and Ghurghurata. Anti-spasmodic property of Pippali, Hingu andBala helps in reducing the pain, therefore significant reduction in Pranaprapeedana andAssenolabhatesaukyam were observed. Vascine andvasicinone which is present in Bala [19] is known for its smooth muscle relaxing effect, thereby it reduces the bronchospasm and normalises the bronchioles for breathing, reduction in the inflammation of bronchial smooth muscle; whichreduces the Duration of symptoms that facilities the easy ventilation in short time. No significant result on parameter of Pramohamight be due to only 3 patients had complaints so, much difference was not noticed.
Significant results on Peak expiratory flow rate shows the ability of the drug in reducing the pathology by bronchodilation, smooth muscle relaxation and expectorant thus helping the patient to breath for maximum capacity. Changes in Chest expansion might be due to increased peak expiratory flow rate helps in the expiratory capacity of the lungs and allowing the lungs to inflate to its maximum limit.Respiratory ratethis might be because vasoconstriction and bronchodilator activity ofHingwadichoorna, which reduces excess pooling of mucous into the bronchial tree making the airflow easy.
No significant results were observed on parameter of Weight because of shorter duration of the study. 
